Download or read book Microangiopathy written by Raimondo De Cristofaro and published by BoD – Books on Demand. This book was released on 2012-03-23 with total page 96 pages. Available in PDF, EPUB and Kindle. Book excerpt: Microangiopathies are pathological processes causing degenerative disorders of small vessels. The circulatory problems caused by microangiopathies may be responsible for failure of individual or multiple organs. These pathological processes are indeed one of the most common disorders characterized by high morbility and mortality in the affected patients. Many studies have revealed very complicated processes both at cellular and molecular level. However, much work remains to define the diversity of different pathogenetic mechanisms leading to microangiopathic disorders to provide appropriate prevention and treatment strategies. The aim of this volume is providing illustrative examples of relevant mechanisms responsible for different forms of microangiopathies and how this body of evidences can be harnessed to define new strategies of therapeutic intervention.

Download or read book Diabetic Macro and Microangiopathy written by Iulian Mincu and published by Walter de Gruyter GmbH & Co KG. This book was released on 2019-05-20 with total page 264 pages. Available in PDF, EPUB and Kindle. Book excerpt: No detailed description available for "Diabetic Macro- and Microangiopathy".

Download or read book Pathogenetic Concepts of Diabetic Microangiopathy written by E. Standl and published by . This book was released on 1981 with total page 127 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Thrombotic Microangiopathy written by Hau C. Kwaan and published by . This book was released on 1987 with total page 72 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Stage specific Evaluation of the Molecular Pathogenesis of Glomerular Thrombotic Microangiopathy in a Gimap8 Mutant Mouse Model written by Thanh-Mai Johanna Lena Le and published by . This book was released on 2013 with total page 204 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Endothelial Cell Function in Diabetic Microangiopathy written by and published by . This book was released on 1990 with total page 228 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Diabetic microangiopathy written by Hiroshi Abe and published by . This book was released on 1983 with total page 497 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Diabetes and the Nervous System written by Douglas W. Zochodne and published by Elsevier. This book was released on 2014-12-26 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This is a unique compilation, by experts worldwide, addressing how diabetes impacts the nervous system. For example, diabetic polyneuropathy, a disorder more common than MS, Parkinson's disease, and ALS combined, is a major source of disability to diabetic persons worldwide. This book addresses diabetic polyneuropathy and how diabetes alters other parts of the nervous system.

Download or read book Thrombotic Microangiopathy written by and published by . This book was released on 1987 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Cerebral Small Vessel Disease written by Leonardo Pantoni and published by Cambridge University Press. This book was released on 2014-05 with total page 375 pages. Available in PDF, EPUB and Kindle. Book excerpt: Up-to-date discussion of the etiology, diagnosis, treatment, and prevention of this common cause of stroke and cognitive impairment.

Download or read book Transplant Associated Thrombotic Microangiopathy in Childhood written by Fatih Erbey and published by . This book was released on 2012 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Transplant-Associated Thrombotic Microangiopathy in Childhood.

Download or read book Diabetic Microangiopathy written by Hiroshi Abe and published by S. Karger AG (Switzerland). This book was released on 1983 with total page 522 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Pathogenetic Concepts of Diabetic Microangiopathy written by Eberhard Standl and published by . This book was released on 1981 with total page 144 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Proceedings of a Conference on Diabetic Microangiopathy written by Conference on Diabetic Microangiopathy. 1976, Santa Ynez, Calif.. and published by . This book was released on 1976 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Determinants of Microangiopathy in Growth onset Diabetes written by Göran Sterky and published by . This book was released on 1986 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura written by Bernard S. Kaplan and published by CRC Press. This book was released on 1992-07-14 with total page 608 pages. Available in PDF, EPUB and Kindle. Book excerpt: This reference presents detailed discussions of the history, pathology, pathophysiology, and approaches to treatment of the complicated, constantly evolving syndromes known as thrombotic thromocytopenic purpura (TTP), from many different points of view. Hemolytic Uremic syndrome and Thrombotic Thrombocytopenic Purpura offers: extensive analyses of the relationship between HUS and TTP; epidemiological studies of HUS from the UK, Canada, Asia, South Africa and Argentina; investigations of non-renal complications of HUS; perspectives on atypical HUS and post-transplantation HUS; delineations of the association between verotoxin and HUS, HUS and pregnancy, and HUS and cancer and cancer tharapy; information on HUS/TTP in HIV-infected patients; explications of the pathology and pathogenesis of HUS; and approaches to treatment of HUS, prognosis, and long-term follow-up.;In addition, it covers the history and pathogenesis of TTP, von Willebrand factor abnormalities in TTP and HUS, platelet agglutinating proteins in TTP, and the treatment of TTP.;With over 2000 literature citations and figures, this book is for nephrologists, hematologists, oncologists, paediatricians, pathologists, gastroenterologists, internists, endocrinologists, infectious disease specialists, neurologists, gynaecologists, microbiologists, surgeons, geneticsts, epidemiologists, radiologists, and medical school students in these disciplines.

Download or read book Interferon Induced Thrombotic Microangiopathy written by Ajay Kundra and published by . This book was released on 2018 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Interferon (IFN) is an effective therapy for multiple disorders. An infrequently reported side effect is thrombotic microangiopathy (TMA): thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). We published the first comprehensive review analyzing this association with the following observations: (1) there was a higher incidence of IFN-induced TMA in myeloproliferative disorders (chronic myelogenous leukemia (CML)) than that in nonmalignant disorders (multiple sclerosis (MS), chronic hepatitis C virus infection (HCV)); (2) mean age at diagnosis was 47 years; (3) there was rare association with hairy cell leukemia (HCL), Sezary syndrome (one case each) and no cases reported for polycythemia vera (PV); (4) sex distribution was balanced (exception of higher prevalence in females for MS); (5) TMA was insidious in onset with long incubation periods (average treatment duration 40.4 months); (6) comparative analysis of mean time (months) to onset of TMA ensuing cumulative IFN exposure was: MS 68.6 vs. CML 35.5 vs. HCV 30.4; (7) confirmed TTP (low ADAMTS 13 levels) was associated with the presence of an inhibitor; (8) outcome analysis revealed complete remission in 27 (40%), persistent chronic kidney disease in 28 (42%) and fatality in 12 patients (18%); (9) corticosteroids, plasma exchange (PEX) and rituximab are effective therapies.